Innovation

Method of inhibiting hepatitis B virus

Institute for Hepatitis and Virus Research
posted on 02/15/2009

A method is disclosed for the treatment of hepatitis B virus (HBV) infections which comprises administering to the infected host an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol in which the alkyl group contains from 3 to 6 carbon atoms.


Innovation Details
 

File Number: 96-1B 

Disease: Infectious Diseases


IP Protection

Patent Number(s): 6037351

License Online

This innovation currently is not available for online licensing. Please contact Ethan Byler at Institute for Hepatitis and Virus Research for more information.

Request more info via email request more info
People

Case Manager:

Ethan Byler Ethan Byler

Innovations (11)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
579

Institute for Hepatitis and Virus Research


Profile
Related Tags

Find more innovations

February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...